Moreover, BBB permeability of the medial temporal lobe is an independent early imaging biomarker of cognitive impairment unrelated to Aβ or tau pathology (43) and global BBB leakage found in patients with early AD is associated with cognitive decline (44). The gene discussed is MAPT; the disease is Alzheimer disease.